Silence Therapeutics PLC (SLN) — Cash Flow Quality Index

Latest as of December 2024: -0.87x

Silence Therapeutics PLC (SLN) has a Cash Flow Quality Index of -0.87x as of December 2024. Operating cash flow of $-19.87 Million is below net income of $22.89 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Silence Therapeutics PLC (SLN) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.87x

Operating CF / Net Income

Operating Cash Flow

$-19.87 Million

USD

Net Income

$22.89 Million

USD

Data as of

Dec 2024

Most recent filing

Annual Cash Flow Quality Index for Silence Therapeutics PLC (None–None)

Year-by-year earnings quality comparison for Silence Therapeutics PLC.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.